Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zenalux’s Zenascope has demonstrated efficacy in pre-clinical and early clinical studies as a real-time diagnostic tool to measure tissue biomarkers relevant to tumor biology. It enables non-destructive assessment of blood concentration, oxygen saturation, cell density, and other metabolic markers in tissues. The device is being evaluated for its ability to accelerate drug discovery feedback loops and improve intraoperative margin assessment during tumor resection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zenalux Biomedical.